What is Idexx Laboratories's tax receivable within other current assets?

Idexx Laboratories (IDXX) reported tax receivable within other current assets of $15.97M in Q1 2026.

How has Idexx Laboratories's tax receivable within other current assets changed year-over-year?

Idexx Laboratories's tax receivable within other current assets increased by 16.1% year-over-year, from $13.76M to $15.97M.

What is the long-term trend for Idexx Laboratories's tax receivable within other current assets?

Over 5 years (2020 to 2025), Idexx Laboratories's tax receivable within other current assets has grown at a 27.3% compound annual growth rate (CAGR), from $19.48M to $64.99M.

What does tax receivable within other current assets mean?

Income tax refunds or credits owed to the company by tax authorities.

Discontinued — last reported Q2 '16

Other

Tax receivable within other current assets

Idexx Laboratories Tax receivable within other current assets decreased by 75.4% to $15.97M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.1%, from $13.76M to $15.97M. Over 5 years (FY 2020 to FY 2025), Tax receivable within other current assets shows an upward trend with a 27.3% CAGR.

Analysis

StatementBalance Sheet Statement

SectionOther

CategoryLiquidity

SignalContext dependent

VolatilityModerate

First reportedQ4 2014

Last reportedQ2 2016

How to read this metric

An increase may indicate overpayment of estimated taxes or the realization of tax credits, while a decrease suggests the collection of these receivables or a shift in tax liability status.

Detailed definition

This represents the amount of income tax overpayments or credits due to the company from tax authorities that are expect...

Peer comparison

Common across all capital-intensive industries; peers typically report this within current assets or as a component of other receivables.

Metric ID: other_income_taxes_receivable

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$17.38M	$16.82M	$19.46M	$21.75M	$19.85M	$22.57M	$48.43M	$27.19M	$20.31M	$18.21M	$16.97M	$14.46M	$15.99M	$14.41M	$26.99M	$13.76M	$35.00M	$76.13M	$64.99M	$15.97M
QoQ Change	—	-3.2%	+15.7%	+11.7%	-8.7%	+13.7%	+114.6%	-43.9%	-25.3%	-10.3%	-6.8%	-14.8%	+10.6%	-9.9%	+87.4%	-49.0%	+154.4%	+117.6%	-14.6%	-75.4%
YoY Change	—	—	—	—	+14.2%	+34.2%	+148.8%	+25.0%	+2.3%	-19.3%	-65.0%	-46.8%	-21.3%	-20.9%	+59.0%	-4.9%	+118.9%	+428.5%	+140.8%	+16.1%

Range$13.76M – $76.13M

CAGR-1.8%

Avg YoY Growth+50.6%

Median YoY Growth+15.1%

Current Streak2 quarters decline

Frequently Asked Questions

What is Idexx Laboratories's tax receivable within other current assets?: Idexx Laboratories (IDXX) reported tax receivable within other current assets of $15.97M in Q1 2026.
How has Idexx Laboratories's tax receivable within other current assets changed year-over-year?: Idexx Laboratories's tax receivable within other current assets increased by 16.1% year-over-year, from $13.76M to $15.97M.
What is the long-term trend for Idexx Laboratories's tax receivable within other current assets?: Over 5 years (2020 to 2025), Idexx Laboratories's tax receivable within other current assets has grown at a 27.3% compound annual growth rate (CAGR), from $19.48M to $64.99M.
What does tax receivable within other current assets mean?: Income tax refunds or credits owed to the company by tax authorities.